Fermion, Simcere

Fermion y Simcere desarrollarán el primer agonista SSTR4 de China dirigido al dolor

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Guangzhou Fermion Technology Co., Ltd. Simcere Pharmaceutical Group Limited China

View original content:https://www.prnewswire.com/news-releases/fermion-y-simcere-desarrollaran-el-primer-agonista-sstr4-de-china-dirigido-al-dolor-302355270.html

en | boerse | 67962854 |